1 / 47

MLAB 2401: Clinical Chemistry Keri Brophy-Martinez

MLAB 2401: Clinical Chemistry Keri Brophy-Martinez. Measurement of Enzymes & Their Clinical Significance. Measurement of Enzyme Activity. Often measured by catalytic activity then related to concentration

Download Presentation

MLAB 2401: Clinical Chemistry Keri Brophy-Martinez

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MLAB 2401: Clinical ChemistryKeri Brophy-Martinez Measurement of Enzymes & Their Clinical Significance

  2. Measurement of Enzyme Activity • Often measured by catalytic activity then related to concentration • Enzyme concentration is best measured by its activity or its rate of activity by observing: • Substrate depletion • Product production • Increase/decrease in cofactor/coenzyme • Usually performed in zero-order kinetics

  3. Measurement of Enzyme Activity Fixed time Continuous Monitoring/Kinetic Multiple measurements of absorbance change are made Advantages Depletion of substrate is observable Improved accuracy • Measurement of the amount of substrate utilized over a fixed amount of time or by a fixed amount of serum • Problems • Long incubation times • Possible enzyme denaturation • Often a lag phase • Possible substrate depletion

  4. Reporting Enzyme Activity • Originally reported as activity units • IUB standardized these as international units (IU) • IU: the amount of enzyme that will convert one micromole of substrate per minute in an assay system • Expressed as units per liter or U/L • Conditions: pH, temperature, substrate,activators • Katal units(SI): express as moles/second

  5. Other Methods to Measure Enzymes • Using Enzyme Mass • Measure protein mass NOT catalytic activity • Electrophoresis • Used to differentiate isoenzymes • Time-consuming

  6. Enzymes of Clinical Significance

  7. Creatine Kinase (CK) • Action • Associated with the regeneration and storage of ATP • Catalyses the following reaction:

  8. Creatine Kinase (CK) • Purpose • Allows the body to store phosphate energy as creatine phosphate • Energy can be released/ provided to muscles by reversing the reaction • Source • Skeletal muscle • Heart • Brain • Other

  9. CreatineKinase (CK):Structure • Dimerconsisting of two subunits • Two subunits are further divided into 3 molecular forms or isoenzymes • CK-BB: (CK-1)brain type • Migrates fast on electrophoresis • Small amount found in tissue (brian, lung, bladder, bowel) • CK-MB: (CK-2)hybrid type • Heart, Skeletal • CK-MM: (CK-3)Muscle type • Mostly found in healthy people • Striated muscle and normal serum

  10. Creatine Kinase (CK) • Diagnostic Use • Appearance of CK (MB) very sensitive indicator of MI • Skeletal muscle disorders such as muscular dystrophy • CNS Disorders • Cerebrovascular accident(CVA) • Seizures • Nerve degeneration

  11. CK Isoenzymes

  12. What’s in a Number?

  13. CreatineKinase: Specimen Collection • Sources of Error • Hemolysis • Interference of adenylatekinase on CK assays • Results in false elevations • Exposure to light • CK is inactivated by light

  14. CreatineKinase: Reference Range • Affected by: • Age • Physical activity • Race • Bed rest (even overnight can decrease CK) • Total CK • Men: 46-180 U/L • Female: 15-171 U/L

  15. Creatine Kinase • Isoenzyme Testing • Fractionation of CK • Immunoinhibition • Mass Assay • Electrophoresis

  16. Lactate Dehydrogenase (LDH/LD) • Action • Catalyzes a reversible reaction between pyruvate and lactate with NAD as a coenzyme • Reaction:

  17. Lactate Dehydrogenase (LDH/LD) • Source • Skeletal muscle • Cardiac muscle • Kidney • RBCs • Widely distributed in the body

  18. Lactate Dehydrogenase (LDH/LD):Structure • Tetramer • Four polypeptide chains, two subunits (heart & muscle) • Five combinations of Isoenzymes

  19. Lactate Dehydrogenase (LDH/LD) • Diagnostic Significance • Nonspecific • Increased • Hematologic and neoplastic disorders • Liver disease • Heart problems

  20. Lactate Dehydrogenase(LDH/ LD):Specimen Collection • Sources of Error • Hemolysis • RBCs contain 100-150 times that found in serum • Analyte stability • Run assay asap or store at room temperature • Prolonged contact of serum and cells • Reference Range • 140- 280 U/L

  21. Liver Enzymes • Transaminases • AST • ALT • Phosphatases • ALP

  22. Transaminases • Retain amino groups during the degradation of amino acids • Types • Aspartate transaminase (AST) • Aka: Glutamic Oxalocetic transaminase (SGOT) • Alanine transaminase (ALT) • AKA: Glutamic pyruvic transaminase (SGPT)

  23. Aspartate Aminotransferase( AST) • Sources • Major • Heart • Liver • Muscle • Minor • RBCs • Kidney • Pancreas • Lung

  24. Aspartate Aminotransferase( AST) • Reaction: AST

  25. AST:Specimen Collection • Sources of Error • Hemolysis • Analyte stability • Stable at room temp for 48 hours or 3-4 days refrigerated • Reference Range • 5-30 U/L

  26. Alanine Transaminase (ALT) • Transfers an amino group from alanine to alpha-ketoglutarate to form glutamate and pyruvate ALT

  27. Alanine Transaminase (ALT) • Sources • Liver (Majority) • Kidney • Heart • Skeletal muscle

  28. ALT:Specimen Collection • Sources of Error • Hemolysis • Analyte stability • 3-4 days refrigerated • Reference Range • 6-37 U/L

  29. Diagnostic Significance: AST & ALT • Many diseases can cause increases since widely distributed in tissues • Liver • Hepatitis • Cirrhosis • Liver cancer • Myocardial Infarction • AST increases most • ALT normal to slightly increased, unless liver damage accompanies • Other • Pulmonary emboli • Muscle injuries • Gangrene • Hemolytic diseases • Progressive Muscular dystrophy

  30. Phosphatases • Removes phosphates from organic compounds • Functions to facilitate transfer of metabolites across cell membranes • Alkaline Phosphatase (ALP) • Acid Phosphatase (ACP)

  31. Phosphatases: Sources Alkaline Phosphatase (ALP) Acid Phosphatase (ACP) Prostate gland Seminal fluid Liver Spleen RBCs Platelets • Bone • Liver • Kidney • Placenta • Intestines

  32. Alkaline Phosphatase (ALP) • ALP frees inorganic phosphate from an organic phosphate monoester, resulting in the production of an alcohol at an alkalinepH • Maximum activity at pH of 9.0- 10.0

  33. Alkaline Phosphatase (ALP) • Diagnostic Significance • Elevations seen in • During bone activity • Paget’s disease • Liver disease, especially in obstructive disorders • Pregnancy between 16-20 weeks gestation • Decreased levels occur, but not diagnostic

  34. Alkaline Phosphatase (ALP):Specimen Collection • Sources of Error • Hemolysis • Delay in processing, false increases can occur • Reference Range (Adult) • 30-90 U/L • NOTE: Normal increases seen in pregnancy, childhood, adolescence

  35. Acid Phosphatase (ACP) • Diagnostic Significance • Aids in detection of prostatic carcinoma • Other conditions associated with prostate • Forensic chemistry: Rape cases • Elevated in bone disease

  36. Acid Phosphatase (ACP):Specimen Collection • Sources of Error • Separate serum from cells asap • Decrease in activity seen at room temp • Hemolysis • Reference Range (prostatic) • 0-4.5 ng/mL

  37. Gamma-Glutamyltransferase (GGT) • Possibly involved in peptide and protein synthesis, transport of amino acids and regulation of tissue glutathione levels • Sources • Kidney • Brain • Prostate • Pancreas • Liver

  38. Gamma-Glutamyltransferase (GGT) • Diagnostic Significance • Sensitive indicator of liver damage • Increased in patients taking enzyme-inducing drugs such as warfarin, phenobarbital and phenytoin • Indicator of alcoholism • Elevated in acute pancreatitis, diabetes mellitus and MI

  39. GGT:Specimen Collection • Sources of Error • Very stable • Hemolysis not an issue • Reference Range • Male: 10-34 U/L • Female: 9-22 U/L

  40. Digestive & Pancreatic Enzymes • Amylase • Lipase

  41. Amylase (AMS) • Digestive enzyme that hydrolzes/catalyzes the breakdown of starch and glycogen to carbohydrates • Smallest enzyme • Sources • Acinar cells of pancreas and salivary glands

  42. Amylase (AMS) • Diagnostic Significance • Acute pancreatitis • AMS levels rise 2-12 hours after onset of attack, peak at 24 hrs and return to normal within 3-5 days • Salivary gland lesions • Mumps

  43. Amylase • Sources of Error • Presence of opiates increases levels • Stabile • Reference Range • Serum: 30-100 U/L • Urine: 1-17 U/h

  44. Lipase (LPS) • Hydrolyzes triglycerides to produce alcohols and fatty acids • Source • Pancreas

  45. Lipase (LPS) • Diagnostic Significance • Acute pancreatitis • More specific than amylase • LPS persists longer than AMS

  46. Lipase:Specimen Collection • Sources of Error • Stabile • Hemolysis results in false decreases • Reference Range • 13-60 U/L

  47. References • Bishop, M., Fody, E., & Schoeff, l. (2010). Clinical Chemistry: Techniques, principles, Correlations. Baltimore: Wolters Kluwer Lippincott Williams & Wilkins. • Sunheimer, R., & Graves, L. (2010). Clinical Laboratory Chemistry. Upper Saddle River: Pearson .

More Related